A prospective study of a urine and plasma biomarker test for the prediction of gleason ≥3 + 4 prostate cancer in a mixed cohort.

Conclusions: We were able to predict the presence of medium-high grade prostate cancer, thereby confirming earlier findings of the biomarker test.
PMID: 32608296 [PubMed - as supplied by publisher]

Source: Scandinavian Journal of Urology - July 3, 2020 Category: Urology & Nephrology Tags: Scand J Urol Source Type: research